Your browser doesn't support javascript.
loading
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib.
Koehler, Anne; Hubert, Karolin; Lange, Thoralf; Siebolts, Udo; Wickenhauser, Claudia; Gopalakrishna, Prashanth; Niederwieser, Dietger; Monecke, Astrid; Al-Ali, Haifa Kathrin.
Afiliación
  • Koehler A; Department of Hematology and Oncology, University of Frankfurt, Frankfurt, Germany.
  • Hubert K; Medizinische Fakultaet, University of Leipzig, Leipzig, Germany.
  • Lange T; Medizinische Fakultaet, University of Leipzig, Leipzig, Germany.
  • Siebolts U; Institute of Pathology, University Hospital of Halle, Halle, Germany.
  • Wickenhauser C; Institute of Pathology, University Hospital of Halle, Halle, Germany.
  • Gopalakrishna P; Novartis Pharma AG, Basel, Switzerland.
  • Niederwieser D; Department of Hematology/Oncology, University Hospital of Leipzig, Leipzig, Germany.
  • Monecke A; Institute of Pathology, University Hospital of Leipzig, Leipzig, Germany.
  • Al-Ali HK; Department of Hematology/Oncology, University Hospital of Leipzig, Leipzig, Germany. alah@medizin.uni-leipzig.de.
Ann Hematol ; 94(11): 1929-30, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26202608

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Janus Quinasa 2 / Mielofibrosis Primaria Límite: Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Janus Quinasa 2 / Mielofibrosis Primaria Límite: Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania